secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001104659-22-117666
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MedTech Acquisition Corp. to merge with TriSalus Life Sciences for $220M in stock
--------------------------------------------------------------------------------

- Merger consideration: $220M paid entirely in MTAC common stock valued at $10.00 per share.
- Closing conditions include MTAC having at least $60M in available cash and net tangible assets ≥$5M.
- Sponsor agrees to forfeit 2,187,500 shares and subject 3,125,000 shares to vesting restrictions.
- Non-binding term sheet for up to $50M of 8.0% senior secured convertible notes from Magnetar Capital.
- TriSalus stockholders subject to 365-day lock-up; lock-up ends earlier if stock hits $12 for 20 of 30 days after 150 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922117666/0001104659-22-117666-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922117666/tm2230343d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-117666

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer